Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Pediatric Rheumatology
Published in: Pediatric Rheumatology 1/2012

Open Access 01-12-2012 | Research

Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA)

Authors: Philomien A van Pelt, Tim Takken, Marco van Brussel, Inge de Witte, Aike A Kruize, Nico M Wulffraat

Published in: Pediatric Rheumatology | Issue 1/2012

Login to get access

Abstract

Background

As patients with juvenile idiopathic arthritis (JIA) progress into adulthood, long-term outcome is determined by disease activity, physical and psychosocial development. Decreased aerobic capacity may play a critical role in health-related outcomes in JIA, since it has been linked with cardiovascular morbidity and mortality in late adulthood. The objectives of the current study are to examine the aerobic capacity and its relation to parameters of disease activity in children, adolescents and young adults with JIA.

Methods

Sixty-three patients with JIA (aged 10–27 years) were cross sectional studied regarding their aerobic capacity and correlations were made to demographic, disease-related variables, and medication utilization. in a cross-sectional study group of 63 patients of all subtypes. Patients were divided in three age groups, 10–13 years; 14–17 years and 18–27 years.

Results

Reduced aerobic capacity is found in clinical remission as well as active disease in all subtypes and all age groups. Aerobic capacity is more impaired in active disease shown by DAS 28, JADAS 27, ESR and serum thrombocyte counts. Lower haemoglobin has a negative impact. Long-term used medication including methotrexate and corticosteroids didn’t influence outcome. There is no association with current sports participation.

Conclusion

Reduced aerobic capacity is present in children and adolescents with JIA, both in active disease and in patients with remission. Measures of aerobic capacity may serve as important outcome measure in JIA.
Appendix
Available only for authorised users
Literature
1.
Flato B, Aasland A, Vinje O, Forre O: Outcome and predictive factors in juvenile rheumatoid arthritis and juvenile spondyloarthropathy. J Rheumatol. 1998, 25 (2): 366-375.PubMed
2.
Fantini F, Gerloni V, Gattinara M, Cimaz R, Arnoldi C, Lupi E: Remission in juvenile chronic arthritis: a cohort study of 683 consecutive cases with a mean 10 year followup. J Rheumatol. 2003, 30 (3): 579-584.PubMed
3.
Packham JC, Hall MA: Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome. Rheumatology (Oxford). 2002, 41 (12): 1428-1435. 10.1093/rheumatology/41.12.1428.CrossRef
4.
Oen K, Malleson PN, Cabral DA, Rosenberg AM, Petty RE, Cheang M: Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort. J Rheumatol. 2002, 29 (9): 1989-1999.PubMed
5.
Solari N, Viola S, Pistorio A, Magni-Manzoni S, Vitale R, Ruperto N: Assessing current outcomes of juvenile idiopathic arthritis: a cross-sectional study in a tertiary center sample. Arthritis Rheum. 2008, 59 (11): 1571-1579. 10.1002/art.24202.CrossRefPubMed
6.
Minden K, Niewerth M, Listing J, Biedermann T, Bollow M, Schontube M: Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum. 2002, 46 (9): 2392-2401. 10.1002/art.10444.CrossRefPubMed
7.
Roubenoff R, Roubenoff RA, Cannon JG, Kehayias JJ, Zhuang H, wson-Hughes B: Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest. 1994, 93 (6): 2379-2386. 10.1172/JCI117244.PubMedCentralCrossRefPubMed
8.
D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM: General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008, 117 (6): 743-753. 10.1161/CIRCULATIONAHA.107.699579.CrossRefPubMed
9.
John H, Kitas G, Toms T, Goodson N: Cardiovascular co-morbidity in early rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2009, 23 (1): 71-82. 10.1016/j.berh.2008.11.007.CrossRefPubMed
10.
Gabriel SE: Why do people with rheumatoid arthritis still die prematurely?. Ann Rheum Dis. 2008, 67 (3): 30-34.
11.
Gabriel SE, Michaud K: Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther. 2009, 11 (3): 229-10.1186/ar2669.PubMedCentralCrossRefPubMed
12.
French AR, Mason T, Nelson AM, O'Fallon WM, Gabriel SE: Increased mortality in adults with a history of juvenile rheumatoid arthritis: a population-based study. Arthritis Rheum. 2001, 44 (3): 523-527. 10.1002/1529-0131(200103)44:3<523::AID-ANR99>3.0.CO;2-1.CrossRefPubMed
13.
14.
Byberg L, Melhus H, Gedeborg R, Sundstrom J, Ahlbom A, Zethelius B: Total mortality after changes in leisure time physical activity in 50 year old men: 35 year follow-up of population based cohort. Br J Sports Med. 2009, 43 (7): 482-PubMed
15.
Caspersen CJ, Powell KE, Christenson GM: Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep. 1985, 100 (2): 126-131.PubMedCentralPubMed
16.
Anonymous: Presidents council on Physical fitness. Research Digest. 2000
17.
Blair SN, Cheng Y, Holder JS: Is physical activity or physical fitness more important in defining health benefits?. Med Sci Sports Exerc. 2001, 33 (6 Suppl): S379-S399.CrossRefPubMed
18.
Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE: Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002, 346 (11): 793-801. 10.1056/NEJMoa011858.CrossRefPubMed
19.
van Brussel M, van Lelieveld OT, van der OT, Engelbert Lelieveld RH, Helders PJ, Tskken T: Aerobic and anaerobic exercise capacity in children with juvenile idiopathic arthritis. Arthritis Rheum. 2007, 57 (6): 891-897. 10.1002/art.22893.CrossRefPubMed
20.
Takken T, Hemel A, Van der NJ, Helders PJ: Aerobic fitness in children with juvenile idiopathic arthritis: a systematic review. J Rheumatol. 2002, 29 (12): 2643-2647.PubMed
21.
Lelieveld OT, van Brussel M, Takken T, van Weert E, van Leeuwen MA, Armbrust W: Aerobic and anaerobic exercise capacity in adolescents with juvenile idiopathic arthritis. Arthritis Rheum. 2007, 57 (6): 898-904. 10.1002/art.22897.CrossRefPubMed
22.
Lelieveld OT, Armbrust W, van Leeuwen MA, Duppen N, Geertzen JH, Sauer PJ: Physical activity in adolescents with juvenile idiopathic arthritis. Arthritis Rheum. 2008, 59 (10): 1379-1384. 10.1002/art.24102.CrossRefPubMed
23.
Houghton KM, Potts JE, Sheel AW, Petty RE, McKenzie DC: Aerobic and anaerobic capacity in Juvenile Idipatic Arthritis: evaluation of the cardiorespiratory response. Internet J Rheumatol. 2008, 5: 2-10.5580/201f.
24.
Lindehammar H, Sandstedt P: Measurement of quadriceps muscle strength and bulk in juvenile chronic arthritis. A prospective, longitudinal, 2 year survey. J Rheumatol. 1998, 25 (11): 2240-2248.PubMed
25.
Mauras N: Growth hormone therapy in the glucocorticosteroid-dependent child: metabolic and linear growth effects. Horm Res. 2001, 56 (Suppl 1): 13-18.CrossRefPubMed
26.
Knook LM, de Kleer IM, van der Ent CK, van der Net JJ, Prakken BJ, Kuis W: Lung function abnormalities and respiratory muscle weakness in children with juvenile chronic arthritis. Eur Respir J. 1999, 14 (3): 529-533. 10.1034/j.1399-3003.1999.14c09.x.CrossRefPubMed
27.
Khadadah ME, Jayakrishnan B, Al Gorair S, Al Mutairi M, Al Maradni N, Onadeko B: Effect of methotrexate on pulmonary function in patients with rheumatoid arthritis–a prospective study. Rheumatol Int. 2002, 22 (5): 204-207. 10.1007/s00296-002-0227-6.CrossRefPubMed
28.
Schmeling H, Stephan V, Burdach S, Horneff G: Pulmonary function in children with juvenile idiopathic arthritis and effects of methotrexate therapy. Z Rheumatol. 2002, 61 (2): 168-172. 10.1007/s003930200025.CrossRefPubMed
29.
Camiciottoli G, Trapani S, Castellani W, Ginanni R, Ermini M, Falcini F: Effect on lung function of methotrexate and non-steroid anti-inflammatory drugs in children with juvenile rheumatoid arthritis. Rheumatol Int. 1998, 18 (1): 11-16. 10.1007/s002960050047.CrossRefPubMed
30.
Metin G, Ozturk L, Kasapcopur O, Apelyan M, Arisoy N: Cardiopulmonary exercise testing in juvenile idiopathic arthritis. J Rheumatol. 2004, 31 (9): 1834-1839.PubMed
31.
Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004, 31 (2): 390-392.PubMed
32.
Singh G, Athreya BH, Fries JF, Goldsmith DP: Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum. 1994, 37 (12): 1761-1769. 10.1002/art.1780371209.CrossRefPubMed
33.
Ruperto N, Ravelli A, Pistorio A, Malattia C, Cavuto S, Gado-West L: Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries. Review of the general methodology. Clin Exp Rheumatol. 2001, 19 (4 Suppl 23): S1-S9.PubMed
34.
Wulffraat N, van der Net JJ, Ruperto N, Kamphuis S, Prakken BJ, ten Cate R: The Dutch version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol. 2001, 19 (4 Suppl 23): S111-S115.PubMed
35.
Dool R, Elling A, Hoekman R:Mulier Instituut iov NOC*NSF. Sporters Monitor 2008; description of actual sportissues. 2009, 1-124.
36.
Brugnara C: Reference values in early childhood. Hematology of infancy and childhood. Edited by: Nathan DG, Orkin SH, Ginsburg D. 2003, Saunders, Philadelphia, USA, 1835-1864. Sixth
37.
Binkhorst RA, van Hof MA, Saris WHM: Maximale inspanning door kinderen; referentiewaarden voor 6–18 jarige meisjes en jongens [Maximal exercise in children; reference values girls and boys, 6–18 year of age]. 1992, Nederlandse Hartstichting, Den-Haag
38.
Consolaro A, Ruperto N, Bazso A, Pistorio A, Magni-Manzoni S, Filocamo G: Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum. 2009, 61 (5): 658-666. 10.1002/art.24516.CrossRefPubMed
39.
Prevoo ML, Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL: Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995, 38 (1): 44-48. 10.1002/art.1780380107.CrossRefPubMed
40.
Wallace CA, Ruperto N, Giannini E: Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol. 2004, 31 (11): 2290-2294.PubMed
41.
Fransen J, Creemers MC, van Riel PL: Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology (Oxford). 2004, 43 (10): 1252-1255. 10.1093/rheumatology/keh297.CrossRef
42.
Takken T, Spermon N, Helders PJ, Prakken AB, Van der NJ: Aerobic exercise capacity in patients with juvenile dermatomyositis. J Rheumatol. 2003, 30 (5): 1075-1080.PubMed
43.
Takken T, Terlingen HC, Helders PJ, Pruijs H, van der Ent CK, Engelbert RH: Cardiopulmonary fitness and muscle strength in patients with osteogenesis imperfecta type I. J Pediatr. 2004, 145 (6): 813-818. 10.1016/j.jpeds.2004.08.003.CrossRefPubMed
44.
Ploeger HE, Takken T, Wilk B, Issenman RM, Sears R, Suri S: Exercise Capacity in Pediatric Patients with Inflammatory Bowel Disease. J Pediatr. 2011, 158 (5): 814-819. 10.1016/j.jpeds.2010.10.020.CrossRefPubMed
45.
Minden K: Adult outcomes of patients with juvenile idiopathic arthritis. Horm Res. 2009, 72 (Suppl 1): 20-25.CrossRefPubMed
46.
Konstantinidou E, Koukouvou G, Kouidi E, Deligiannis A, Tourkantonis A: Exercise training in patients with end-stage renal disease on hemodialysis: comparison of three rehabilitation programs. J Rehabil Med. 2002, 34 (1): 40-45. 10.1080/165019702317242695.CrossRefPubMed
47.
Harvey AR, Pippard MJ, Ansell BM: Microcytic anaemia in juvenile chronic arthritis. Scand J Rheumatol. 1987, 16 (1): 53-59.PubMed
48.
Lemmey AB, Marcora SM, Chester K, Wilson S, Casanova F, Maddison PJ: Effects of high-intensity resistance training in patients with rheumatoid arthritis: a randomized controlled trial. Arthritis Rheum. 2009, 61 (12): 1726-1734. 10.1002/art.24891.CrossRefPubMed
49.
Gualano B, Sa Pinto AL, Perondi B, Leite Prado DM, Omori C, Ammeida RT: Evidence for prescribing exercise as treatment in pediatric rheumatic diseases. Rev Autoimmun. 2010, 9 (8): 569-573. 10.1016/j.autrev.2010.04.001.CrossRef
Metadata
Title
Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA)
Authors
Philomien A van Pelt
Tim Takken
Marco van Brussel
Inge de Witte
Aike A Kruize
Nico M Wulffraat
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Pediatric Rheumatology / Issue 1/2012
Electronic ISSN: 1546-0096
DOI
https://doi.org/10.1186/1546-0096-10-27

Other articles of this Issue 1/2012

Pediatric Rheumatology 1/2012 Go to the issue

Short Report

Hemolytic anemia following intravenous immunoglobulin therapy in patients treated for Kawasaki disease: a report of 4 cases

Research

Juvenile idiopathic arthritis in two tertiary centres in the Western Cape, South Africa

Case Report

Fatal myocarditis in a child with systemic onset juvenile idiopathic arthritis during treatment with an interleukin 1 receptor antagonist

Research

A comparative proteomic study of sera in paediatric systemic lupus erythematosus patients and in healthy controls using MALDI-TOF-TOF and LC MS–A pilot study

Research

Youth report of healthcare transition counseling and autonomy support from their rheumatologist

Research

Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis